Home > Insider Trading > Filing (0001144204-14-033163)

Filing Details

Accession Number:: 0001144204-14-033163
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-22 16:36:06
Reporting Period:: 2014-05-21

Filing Date:: 2014-05-22
Accepted Time:: 2014-05-22 16:36:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1426800	Ventrus Biosciences Inc	VTUS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1374805	H Russell Ellison	99 Hudson Street 5Th Floor New York NY US 10013	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-21	10,000	$0.87	25,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (right to buy)	$3.81	2024-01-15	395,500	395,500	Direct
Common Stock	Restricted Stock Units	$0.00	2016-06-30	200,000	150,000	Direct
Common Stock	Phantom Stock	$0.00		50,000	50,000	Direct
Common Stock	Stock Options (right to buy)	$8.10	2022-01-15	60,000	60,000	Direct
Common Stock	Stock Options (right to buy)	$6.00	2020-12-22	573,599	573,599	Direct
Common Stock	Warrants (right to buy)	$7.69	2014-11-08	8,065	8,065	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-01-15	395,500	395,500	Direct
2016-06-30	200,000	150,000	Direct
	50,000	50,000	Direct
2022-01-15	60,000	60,000	Direct
2020-12-22	573,599	573,599	Direct
2014-11-08	8,065	8,065	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $.8697 to $.87. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the trades were effected.
The options vest 1/3 on 1/15/2015, and the remaining 2/3 will vest in equal installments on the second and third anniversaries after 1/15/2014.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The restricted stock units vest in four equal amounts (25% each) as follows: 25% on the date of grant and 25% when the 20 trading day volume weighted average price of the Issuer's common stock equals or exceeds $4.15, $5.15 and $6.15. The unvested restricted stock units expire on June 30, 2016 if a vesting threshold has not been met by that date.
Upon the immediate vesting on April 5, 2013 of 50,000 restricted stock units granted to the reporting person on April 5, 2013, the reporting person elected to defer the receipt of those 50,000 shares of common stock, resulting in the accrual to his phantom stock account of 50,000 shares of phantom stock.
Each share of phantom stock represents the right to receive one share of the Issuer's common stock.
The phantom stock becomes payable on the earliest to occur of (a) termination of employment, (b) a change in control of the Issuer, or (c) April 1, 2015.
The options vested 1/3 on 1/15/2013, and the remaining 2/3 will vest in equal installments on the second and third anniversaries after 1/15/2013.
The options vest 1/3 on 12/22/2010, and the remaining 2/3 will vest in equal installments on the second and third anniversaries after 12/22/2010.
The warrant vested in three installments on 3/21/08 (2,689 shares), 3/21/2009 (2,688 shares) and 3/21/2010 (2,688 shares).